Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Facebook Inc (FB): Small Caps Are Still Crushing the S&P 500

Investors in the S&P 500 can’t really complain about the solid double-digit percentage gains they’ve enjoyed so far this year. But compared with the S&P 500’s returns, small-cap stocks have provide much stronger profits for investors — even as many begin to question how much further the long bull market can push higher.

Small-cap superiority

Small-cap stocks have much different characteristics from their larger counterparts. Overall, the stocks that make it into the S&P 500 earn their way by producing monumental growth, demonstrating an ability to become important players, if not outright leaders, in their respective industries.

But by the time a stock actually gets into the S&P 500, much of its growth prospects are behind it. For instance, Facebook Inc (NASDAQ:FB) went through its most important growth phase before it even traded as a public company. Even now, the social-media company has bounced back from more than a year of underperformance, yet Standard & Poor’s still hasn’t seen fit to grant Facebook admittance to its benchmark index.

Over the past few months, small-cap stocks have greatly outpaced the S&P 500:

SPY Total Return Price Chart

Total Return data by YCharts.

What’s particularly interesting about this chart is that it covers both the declines in late June, prompted by fears of the Federal Reserve’s tapering of quantitative easing, and the subsequent rally as investors downplayed those fears. The SPDR S&P 600 Small Cap ETF (NYSEARCA:SLY) beat out both SPDR S&P MidCap 400 ETF (NYSEARCA:MDY) and the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) both during the downturn and during the subsequent bounce.

Small caps have always been special

But before you dismiss this as simply a quirk of short-term performance, take a look at this longer-term chart.

SPY Total Return Price Chart

Total Return Price data by YCharts.

Over the past decade, through good times and bad, small- and mid-cap stocks have consistently beaten large caps. Especially since the financial crisis, small caps have taken off, leaving the S&P 500 behind.

What’s behind small-cap success?

In the big picture, the success of small-cap stocks is a testament to the American model of capitalism. Large companies wield a great deal of power, but they nevertheless have proved unable to hold back up-and-coming competitors that have innovative new ideas. New businesses continually disrupt existing industries, rendering even the oldest and best-established companies obsolete with their advances. As long as America values entrepreneurial spirit, small-cap stocks will continue to have the potential to produce the lucrative returns that their investors have enjoyed for decades.

Today’s unknown small caps will grow into the great companies that most deserve your long-term investing capital. The Motley Fool’s free report “3 Stocks That Will Help You Retire Rich” names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

The article Small Caps Are Still Crushing the S&P 500 originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter: @DanCaplinger. The Motley Fool recommends and owns shares of Facebook. Try any of our Foolish newsletter services free for 30 days. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!